Director Earl Collier not standing for re-election at May 22, 2025 annual meeting

CAPRICOR THERAPEUTICS, INC.

Earl Collier will not stand for re-election to the Board at the May 22, 2025 Annual Meeting.
His departure is not due to any disagreement with the Company's operations, policies, or practices.
Company plans to enter into a consulting agreement with Collier for strategic advisory services.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Earl Collier

Director

CAPR · CAPRICOR THERAPEUTICS, INC.

Effective: 2025-05-22
Filed: April 8, 2025, 7:59 PM ET

On April 8, 2025, Mr. Earl Collier, a member of the Board of Directors (the “Board”) of Capricor Therapeutics, Inc., a Delaware corporation (the “Company”), informed the Board he will not stand for re-election to the Board following the Annual Meeting of Shareholders which is scheduled to occur on May 22, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Earl Collier resigned as Director at CAPRICOR THERAPEUTICS, INC..

Action: resigned
Role: Director

Exact text from the filing

On April 8, 2025, Mr. Earl Collier, a member of the Board of Directors (the “Board”) of Capricor Therapeutics, Inc., a Delaware corporation (the “Company”), informed the Board he will not stand for re-election to the Board following the Annual Meeting of Shareholders which is scheduled to occur on May 22, 2025.

View on SEC.gov

CAPRICOR THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001558370-25-004605

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.